SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    David J. Handelsman, Endocrinology: Adult and Pediatric, 2016,

    CrossRef

  2. 2
    Annelie Hansson, Heather Knych, Scott Stanley, Mario Thevis, Ulf Bondesson, Mikael Hedeland, Characterization of equine urinary metabolites of selective androgen receptor modulators (SARMs) S1, S4 and S22 for doping control purposes, Drug Testing and Analysis, 2015, 7, 8
  3. 3
    Wilhelm Schänzer, Mario Thevis, Human sports drug testing by mass spectrometry, Mass Spectrometry Reviews, 2015, 34, 5
  4. 4
    H. Geyer, W. Schanzer, M. Thevis, Anabolic agents: recent strategies for their detection and protection from inadvertent doping, British Journal of Sports Medicine, 2014, 48, 10, 820

    CrossRef

  5. 5
    Borislav Starcevic, Brian D. Ahrens, Anthony W. Butch, Detection of the selective androgen receptor modulator S-4 (Andarine) in a doping control sample, Drug Testing and Analysis, 2013, 5, 5
  6. 6
    Mario Thevis, Thomas Piper, Simon Beuck, Hans Geyer, Wilhelm Schänzer, Expanding sports drug testing assays: Mass spectrometric characterization of the selective androgen receptor modulator drug candidates RAD140 and ACP-105, Rapid Communications in Mass Spectrometry, 2013, 27, 11
  7. 7
    Eva de Rijke, Martien L. Essers, Jeroen C.W. Rijk, Mario Thevis, Toine F.H. Bovee, Leendert A. van Ginkel, Saskia S. Sterk, Selective androgen receptor modulators:in vitroandin vivometabolism and analysis, Food Additives & Contaminants: Part A, 2013, 30, 9, 1517

    CrossRef

  8. 8
    Mario Thevis, Andreas Thomas, Valentin Pop, Wilhelm Schänzer, Ultrahigh pressure liquid chromatography–(tandem) mass spectrometry in human sports drug testing: Possibilities and limitations, Journal of Chromatography A, 2013, 1292, 38

    CrossRef

  9. 9
    Oliver Krug, Andreas Thomas, Simon Beuck, Ina Schenk, Marc Machnik, Wilhelm Schänzer, Ulf Bondesson, Mikael Hedeland, Mario Thevis, Characterization of In Vitro Synthesized Equine Metabolites of the Selective Androgen Receptor Modulators S24 and S4, Journal of Equine Veterinary Science, 2012, 32, 9, 562

    CrossRef

  10. 10
    W.M.A. Niessen, Fragmentation of toxicologically relevant drugs in negative-ion liquid chromatography–tandem mass spectrometry, Mass Spectrometry Reviews, 2012, 31, 6
  11. 11
    P Teale, J Scarth, S Hudson, Impact of the emergence of designer drugs upon sports doping testing, Bioanalysis, 2012, 4, 1, 71

    CrossRef

  12. 12
    Hao-Yang Wang, Xu Chu, Zhi-Xiong Zhao, Xiao-Shuang He, Yin-Long Guo, Analysis of low molecular weight compounds by MALDI-FTICR-MS, Journal of Chromatography B, 2011, 879, 17-18, 1166

    CrossRef

  13. 13
    Mario Thevis, Andreas Thomas, Wilhelm Schänzer, Current role of LC-MS(/MS) in doping control, Analytical and Bioanalytical Chemistry, 2011, 401, 2, 405

    CrossRef

  14. 14
    S. Guddat, E. Solymos, A. Orlovius, A. Thomas, G. Sigmund, H. Geyer, M. Thevis, W. Schänzer, High-throughput screening for various classes of doping agents using a new ‘dilute-and-shoot’ liquid chromatography-tandem mass spectrometry multi-target approach, Drug Testing and Analysis, 2011, 3, 11-12
  15. 15
    Mario Thevis, Andreas Thomas, Ines Möller, Hans Geyer, James T. Dalton, Wilhelm Schänzer, Mass spectrometric characterization of urinary metabolites of the selective androgen receptor modulator S-22 to identify potential targets for routine doping controls, Rapid Communications in Mass Spectrometry, 2011, 25, 15
  16. 16
    Elia Grata, Laurent Perrenoud, Martial Saugy, Norbert Baume, SARM-S4 and metabolites detection in sports drug testing: A case report, Forensic Science International, 2011, 213, 1-3, 104

    CrossRef

  17. 17
    Mario Thevis, Hans Geyer, Andreas Thomas, Wilhelm Schänzer, Trafficking of drug candidates relevant for sports drug testing: Detection of non-approved therapeutics categorized as anabolic and gene doping agents in products distributed via the Internet, Drug Testing and Analysis, 2011, 3, 5
  18. 18
    E. Gerace, A. Salomone, F. Fasano, R. Costa, D. Boschi, A. Di Stilo, M. Vincenti, Validation of a GC/MS method for the detection of two quinolinone-derived selective androgen receptor modulators in doping control analysis, Analytical and Bioanalytical Chemistry, 2011, 400, 1, 137

    CrossRef

  19. 19
    Mario Thevis, Enrico Gerace, Andreas Thomas, Simon Beuck, Hans Geyer, Nils Schlörer, Jeffrey D. Kearbey, James T. Dalton, Wilhelm Schänzer, Characterization of in vitro generated metabolites of the selective androgen receptor modulators S-22 and S-23 and in vivo comparison to post-administration canine urine specimens, Drug Testing and Analysis, 2010, 2, 11-12
  20. 20
    Andreas Thomas, Sven Guddat, Maxie Kohler, Oliver Krug, Wilhelm Schänzer, Michael Petrou, Mario Thevis, Comprehensive plasma-screening for known and unknown substances in doping controls, Rapid Communications in Mass Spectrometry, 2010, 24, 8
  21. 21
    Mario Thevis, Andreas Thomas, Gregor Fußhöller, Simon Beuck, Hans Geyer, Wilhelm Schänzer, Mass spectrometric characterization of urinary metabolites of the selective androgen receptor modulator andarine (S-4) for routine doping control purposes, Rapid Communications in Mass Spectrometry, 2010, 24, 15
  22. 22
    Maria K. Parr, Ulrich Flenker, Wilhelm Schänzer, Sports-Related Issues and Biochemistry of Natural and Synthetic Anabolic Substances, Endocrinology and Metabolism Clinics of North America, 2010, 39, 1, 45

    CrossRef

  23. 23
    Michaela Scigelova, Alexander Makarov, Advances in bioanalytical LC–MS using the Orbitrap™ mass analyzer, Bioanalysis, 2009, 1, 4, 741

    CrossRef

  24. 24
    Mario Thevis, Tiia Kuuranne, Hans Geyer, Wilhelm Schänzer, Annual banned-substance review: the Prohibited List 2008—analytical approaches in human sports drug testing, Drug Testing and Analysis, 2009, 1, 1
  25. You have free access to this content25
    Current Awareness in Drug Testing and Analysis, Drug Testing and Analysis, 2009, 1, 4
  26. 26
    Mario Thevis, Hans Geyer, Matthias Kamber, Wilhelm Schänzer, Detection of the arylpropionamide-derived selective androgen receptor modulator (SARM) S-4 (Andarine) in a black-market product, Drug Testing and Analysis, 2009, 1, 8
  27. 27
    Mario Thevis, Simon Beuck, Andreas Thomas, Birthe Kortner, Maxie Kohler, Grigory Rodchenkov, Wilhelm Schänzer, Doping control analysis of emerging drugs in human plasma – identification of GW501516, S-107, JTV-519, and S-40503, Rapid Communications in Mass Spectrometry, 2009, 23, 8
  28. 28
    Mario Thevis, Andreas Thomas, Maxie Kohler, Simon Beuck, Wilhelm Schänzer, Emerging drugs: mechanism of action, mass spectrometry and doping control analysis, Journal of Mass Spectrometry, 2009, 44, 4
  29. 29
    Paul Trevorrow, Launch Editorial, Drug Testing and Analysis, 2009, 1, 1
  30. 30
    Mario Thevis, Simon Beuck, Andreas Thomas, Maxie Kohler, Nils Schlörer, Ileana Vajiala, Wilhelm Schänzer, Screening for the calstabin-ryanodine receptor complex stabilizers JTV-519 and S-107 in doping control analysis, Drug Testing and Analysis, 2009, 1, 1
  31. 31
    A.G. Fragkaki, Y.S. Angelis, M. Koupparis, A. Tsantili-Kakoulidou, G. Kokotos, C. Georgakopoulos, Structural characteristics of anabolic androgenic steroids contributing to binding to the androgen receptor and to their anabolic and androgenic activities, Steroids, 2009, 74, 2, 172

    CrossRef

  32. 32
    Larry D. Bowers, The Analytical Chemistry of Drug Monitoring in Athletes, Annual Review of Analytical Chemistry, 2009, 2, 1, 485

    CrossRef

  33. You have free access to this content33
    Current literature in mass spectrometry, Journal of Mass Spectrometry, 2008, 43, 9
  34. 34
    Mario Thevis, Wilhelm Schänzer, Illicit organogenesis, Organogenesis, 2008, 4, 4, 264

    CrossRef

  35. 35
    Mario Thevis, Wilhelm Schänzer, Leistungssteigernde Substanzen im LC-MS/MS, Nachrichten aus der Chemie, 2008, 56, 9
  36. 36
    Michaela Scigelova, Alexander Makarov, Fundamentals and Advances of Orbitrap Mass Spectrometry, Encyclopedia of Analytical Chemistry,
  37. 37
    Mass Spectrometry and the List of Prohibited Substances and Methods of Doping,
  38. 38
    Structure Characterization of Low Molecular Weight Target Analytes—Electron Ionization,
  39. 39
    Structure Characterization of Low Molecular Weight Target Analytes: Electrospray Ionization,